The Group performed well and the progress reported in the Interim Results has continued with the Group delivering a strong second half to the year. Group revenue is ahead of last year and Group trading profits* and margins are both ahead of last year and expectations.
Healthcare continues to deliver strong performance with annual revenue growth of 26.4%, or 19.2% at constant exchange rates, with margins maintained year on year. It is delivering on the strategy to become the turnkey solution provider of choice for leading global healthcare companies. We recently signed a six-year contract extension with Convatec, a world leading Wound Therapeutics company, further strengthening this strategic relationship.